NKX3.1
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
NKX3.1 is a relatively new immunostain for prostate cancer.
Positive
Rarely positive
- Invasive ductal carcinoma of the breast ~2% of cases.[2]
- Invasive lobular carcinoma ~10% of cases.[2]
See also
References
- ↑ Gordetsky, J.; Epstein, JI. (Jul 2014). "Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.". Am J Surg Pathol 38 (7): 941-5. doi:10.1097/PAS.0000000000000178. PMID 24503758.
- ↑ 2.0 2.1 Asch-Kendrick, RJ.; Samols, MA.; Lilo, MT.; Subhawong, AP.; Sharma, R.; Illei, PB.; Argani, P.; Cimino-Mathews, A. (Sep 2014). "NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas.". J Clin Pathol 67 (9): 768-71. doi:10.1136/jclinpath-2014-202272. PMID 24996432.